189 related articles for article (PubMed ID: 28187092)
1. Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program.
Graul A; Latif N; Zhang X; Dean LT; Morgan M; Giuntoli R; Burger R; Kim S; Ko E
Int J Gynecol Cancer; 2017 Mar; 27(3):581-587. PubMed ID: 28187092
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk?
Swift BE; Maeda A; Bouchard-Fortier G
Gynecol Oncol; 2022 Feb; 164(2):311-317. PubMed ID: 34920887
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.
Chong W; Bui AH; Menhaji K
Am J Obstet Gynecol; 2020 Aug; 223(2):268.e1-268.e26. PubMed ID: 32413430
[TBL] [Abstract][Full Text] [Related]
4. Risk of Venous Thromboembolism After Laparoscopic Surgery for Gynecologic Malignancy.
Mahdi H; Aljebori Q; Lockart D; Moulton L
J Minim Invasive Gynecol; 2016; 23(7):1057-1062. PubMed ID: 27353413
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism in patients with cancer undergoing surgical exploration.
Ruff SM; Weber KT; Khader A; Conte C; Kadison A; Sullivan J; Wang J; Zaidi R; Deutsch GB
J Thromb Thrombolysis; 2019 Feb; 47(2):316-323. PubMed ID: 30560488
[TBL] [Abstract][Full Text] [Related]
6. Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?
Bouchard-Fortier G; Geerts WH; Covens A; Vicus D; Kupets R; Gien LT
Gynecol Oncol; 2014 Aug; 134(2):228-32. PubMed ID: 24875122
[TBL] [Abstract][Full Text] [Related]
7. Postoperative venous thromboembolism in gynecologic oncology patients undergoing minimally invasive surgery: Does modality matter?
Wagar MK; Sobecki JN; Chandereng T; Hartenbach EM; Wallace SK
Gynecol Oncol; 2021 Sep; 162(3):751-755. PubMed ID: 34148718
[TBL] [Abstract][Full Text] [Related]
8. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery.
Nick AM; Schmeler KM; Frumovitz MM; Soliman PT; Spannuth WA; Burzawa JK; Coleman RL; Wei C; Dos Reis R; Ramirez PT
Obstet Gynecol; 2010 Oct; 116(4):956-961. PubMed ID: 20859161
[TBL] [Abstract][Full Text] [Related]
9. Incidence and factors associated with venous thromboembolism in women with gynecologic cancer.
Trugilho IA; Renni MJP; Medeiros GC; Thuler LCS; Bergmann A
Thromb Res; 2020 Jan; 185():49-54. PubMed ID: 31759190
[TBL] [Abstract][Full Text] [Related]
10. Validation of a venous thromboembolism risk assessment model in gynecologic oncology.
Stroud W; Whitworth JM; Miklic M; Schneider KE; Finan MA; Scalici J; Reed E; Bazzett-Matabele L; Straughn JM; Rocconi RP
Gynecol Oncol; 2014 Jul; 134(1):160-3. PubMed ID: 24796634
[TBL] [Abstract][Full Text] [Related]
11. Pattern of Venous Thromboembolism Occurrence in Gynecologic Malignancy: Incidence, Timing, and Distribution a 10-Year Retrospective Single-institutional Study.
Ye S; Zhang W; Yang J; Cao D; Huang H; Wu M; Lang J; Shen K
Medicine (Baltimore); 2015 Dec; 94(50):e2316. PubMed ID: 26683971
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Venous Thromboembolism After Different Modes of Gynecologic Surgery.
Jorgensen EM; Li A; Modest AM; Leung K; Moore Simas TA; Hur HC
Obstet Gynecol; 2018 Nov; 132(5):1275-1284. PubMed ID: 30303902
[TBL] [Abstract][Full Text] [Related]
13. Thromboprophylaxis in gynecologic cancer surgery: Is extended prophylaxis with low molecular weight heparin justified?
Marques de Marino P; Rial Horcajo R; Garcia Grandal T; Sanchez Hervas L; Serrano Hernando FJ; Herraiz Martinez MA; Coronado Martin PJ
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():90-95. PubMed ID: 30245443
[TBL] [Abstract][Full Text] [Related]
14. Effect of length of surgery on the incidence of venous thromboembolism after benign hysterectomy.
Moulder JK; Moore KJ; Strassle PD; Louie M
Am J Obstet Gynecol; 2021 Apr; 224(4):364.e1-364.e7. PubMed ID: 33039394
[TBL] [Abstract][Full Text] [Related]
15. Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications.
Cory L; Latif N; Brensinger C; Zhang X; Giuntoli RL; Burger RA; Morgan M; Ko E
Obstet Gynecol; 2017 Aug; 130(2):285-295. PubMed ID: 28697106
[TBL] [Abstract][Full Text] [Related]
16. A protocol of dual prophylaxis for venous thromboembolism prevention in gynecologic cancer patients.
Einstein MH; Kushner DM; Connor JP; Bohl AA; Best TJ; Evans MD; Chappell RJ; Hartenbach EM
Obstet Gynecol; 2008 Nov; 112(5):1091-7. PubMed ID: 18978110
[TBL] [Abstract][Full Text] [Related]
17. Single-port laparoscopy in gynecologic oncology: seven years of experience at a single institution.
Moulton L; Jernigan AM; Carr C; Freeman L; Escobar PF; Michener CM
Am J Obstet Gynecol; 2017 Nov; 217(5):610.e1-610.e8. PubMed ID: 28619688
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy.
Nagata C; Tanabe H; Takakura S; Narui C; Saito M; Yanaihara N; Okamoto A
J Obstet Gynaecol Res; 2015 Sep; 41(9):1440-8. PubMed ID: 26111609
[TBL] [Abstract][Full Text] [Related]
19. The Safety and Feasibility of Gynecologic Cancer Surgery Combined With Surgery for Pelvic Floor Dysfunction.
McConnell NJ; Stewart JR; Martin A; Gaskins JT; Medlin EE
Female Pelvic Med Reconstr Surg; 2020 Sep; 26(9):563-569. PubMed ID: 30362993
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism following gynaecological surgery for suspected or confirmed malignancy.
Hitos K; Wain GV; Fletcher JP
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):23-7. PubMed ID: 21951130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
